Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience

Geriatrics and Gerontology International

Volumn 12, Issue 4, 2012, Pages 586-599

  Umahara, Takahiko ^a,b   Uchihara, Toshiki ^b   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

14 3 3 proteins; Alzheimer's disease; Atherosclerosis; Cerebral infarction; Neurogenesis; Polyglutamine disease

Indexed keywords

ALPHA SYNUCLEIN; APOPTOSIS SIGNAL REGULATING KINASE 1; ATAXIN 1; BREAKPOINT CLUSTER REGION PROTEIN; ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYGLUTAMINE; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE B; RAF PROTEIN; TAU PROTEIN; TRANSCRIPTION FACTOR FKHR; TRYPTOPHAN HYDROXYLASE;

ALZHEIMER DISEASE; APOPTOSIS; ATHEROGENESIS; BRAIN ATHEROSCLEROSIS; BRAIN DEVELOPMENT; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL SURVIVAL; CREUTZFELDT JAKOB DISEASE; DIFFUSE LEWY BODY DISEASE; GERIATRIC DISORDER; HUMAN; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; POSTNATAL DEVELOPMENT; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SPINOCEREBELLAR DEGENERATION;

14-3-3 PROTEINS; ANIMALS; BRAIN DISEASES; GERIATRICS; HUMANS; NEUROSCIENCES; PROTEIN ISOFORMS;

EID: 84866758053     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2012.00860.x     Document Type: Review

References (88)

1. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol 2006; 16: 162-172.
2. Aitken A, Collinge DB, van Heusden BP etal. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 1992; 17: 498-501.
3. Taya S, Shinoda T, Tsuboi D etal. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 2007; 27: 15-26.
4. Obsil T, Obsilova V. Structural basis of 14-3-3 protein functions. Semin Cell Dev Biol 2011; 22: 663-672.
5. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003; 4: 752-762.
6. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87: 619-628.
7. Chen HK, Fernandez-Funez P, Acevedo SF etal. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 2003; 113: 457-468.
8. Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci 2004; 117: 1875-1884.
9. Mhawech P. 14-3-3 proteins - an update. Cell Res 2005; 15: 228-236.
10. Muslin AJ, Lau JM. Differential functions of 14-3-3 isoforms in vertebrate development. Curr Top Dev Biol 2005; 65: 211-228.
11. Skoulakis EM, Davis RL. 14-3-3 proteins in neuronal development and function. Mol Neurobiol 1998; 16: 269-284.
12. Takahashi Y. The 14-3-3 proteins: gene, gene expression, and function. Neurochem Res 2003; 28: 1265-1273.
13. Tzivion G, Avruch J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 2002; 277: 3061-3064.
14. Tzivion G, Shen YH, Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 2001; 20: 6331-6338.
15. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 2005; 170: 295-304.
16. Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci Lett 1996; 209: 57-60.
17. Umahara T, Uchihara T, Tsuchiya K etal. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol 2004; 108: 279-286.
18. Umahara T, Uchihara T, Tsuchiya K etal. Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci Lett 2004; 371: 215-219.
19. Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 2002; 61: 245-253.
20. Kawamoto Y, Akiguchi I, Nakamura S, Budka H. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 2002; 52: 722-731.
21. Umahara T, Uchihara T. 14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology. Cerebellum 2010; 9: 183-189.
22. Umahara T, Uchihara T, Yagishita S, Nakamura A, Tsuchiya K, Iwamoto T. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1. Neurosci Lett 2007; 414: 130-135.
23. Urano T, Saito T, Tsukui T etal. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 2002; 417: 871-875.
24. Urano T, Takahashi S, Suzuki T etal. 14-3-3sigma is down-regulated in human prostate cancer. Biochem Biophys Res Commun 2004; 319: 795-800.
25. Umahara T, Uchihara T, Nakamura A, Iwamoto T. Isoform-dependent immunolocalization of 14-3-3 proteins in developing rat cerebellum. Brain Res 2009; 1253: 15-26.
26. Umahara T, Uchihara T, Nakamura A, Iwamoto T. Differential expression of 14-3-3 protein-isoforms in developing rat hippocampus, cortex, rostral migratory stream, olfactory bulb, and white matter. Brain Res 2011; 1410: 1-11.
27. Toyo-oka K, Shionoya A, Gambello MJ etal. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 2003; 34: 274-285.
28. Zhang J, Popken GJ, Ye P, D'Ercole AJ. Down-regulation of 14-3-3 eta gene expression by IGF-I in mouse cerebellum during postnatal development. Brain Res Dev Brain Res 2003; 143: 199-206.
29. Baxter HC, Liu WG, Forster JL, Aitken A, Fraser JR. Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 2002; 109: 5-14.
30. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T. Intranuclear localization and isoform-dependent translocation of 14-3-3 proteins in human brain with infarction. J Neurol Sci 2007; 260: 159-166.
31. Sahara N, Maeda S, Takashima A. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. Curr Alzheimer Res 2008; 5: 591-598.
32. Hashiguchi M, Sobue K, Paudel HK. 14-3-3zeta is an effector of tau protein phosphorylation. J Biol Chem 2000; 275: 25247-25254.
33. Agarwal-Mawal A, Qureshi HY, Cafferty PW etal. 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 2003; 278: 12722-12728.
34. Yuan Z, Agarwal-Mawal A, Paudel HK. 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain. J Biol Chem 2004; 279: 26105-26114.
35. Matthews TA, Johnson GV. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models. Neurosci Lett 2005; 384: 211-216.
36. Uchihara T, Nakamura A, Yamazaki M, Mori O. Tau-positive neurons in corticobasal degeneration and Alzheimer's disease - distinction by thiazin red and silver impregnations. Acta Neuropathol 2000; 100: 385-389.
37. Uchihara T, Nakamura A, Yamazaki M, Mori O. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 2001; 101: 535-539.
38. Uchihara T, Nakamura A, Yamazaki M, Mori O, Ikeda K, Tsuchiya K. Different conformation of neuronal tau deposits distinguished by double immunofluorescence with AT8 and thiazin red combined with Gallyas method. Acta Neuropathol 2001; 102: 462-466.
39. Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009; 284: 12845-12852.
40. Sadik G, Tanaka T, Kato K etal. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem 2009; 108: 33-43.
41. Sadik G, Tanaka T, Kato K, Yanagi K, Kudo T, Takeda M. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein. Biochem Biophys Res Commun 2009; 383: 37-41.
42. Sluchanko NN, Seit-Nebi AS, Gusev NB. Phosphorylation of more than one site is required for tight interaction of human tau protein with 14-3-3zeta. FEBS Lett 2009; 583: 2739-2742.
43. Sluchanko NN, Seit-Nebi AS, Gusev NB. Effect of phosphorylation on interaction of human tau protein with 14-3-3zeta. Biochem Biophys Res Commun 2009; 379: 990-994.
44. Mateo I, Sanchez-Juan P, Rodriguez-Rodriguez E etal. 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk. Dement Geriatr Cogn Disord 2008; 25: 317-320.
45. Mateo I, Llorca J, Infante J, Rodriguez-Rodriguez E, Berciano J, Combarros O. Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk. Eur J Neurol 2008; 15: 219-222.
46. Uchihara T, Ikeda K, Tsuchiya K. Pick body disease and Pick syndrome. Neuropathology 2003; 23: 318-326.
47. Uchihara T, Tsuchiya K. Pick body disease: a proposal. Neuropathology 2000; 20: 246.
48. Uchihara T, Tsuchiya K. Neuropathology of Pick body disease. Handb Clin Neurol 2008; 89: 415-430.
49. McKeith IG, Galasko D, Kosaka K etal. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
50. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol 1984; 3: 185-192.
51. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
52. Ostrerova N, Petrucelli L, Farrer M etal. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 1999; 19: 5782-5791.
53. Berg D, Riess O, Bornemann A. Specification of 14-3-3 proteins in Lewy bodies. Ann Neurol 2003; 54: 135.
54. Shirakashi Y, Kawamoto Y, Tomimoto H, Takahashi R. Ihara M. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice. Acta Neuropathol 2006; 112: 681-689.
55. Yacoubian TA, Slone SR, Harrington AJ etal. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis 2010; 1: e2.
56. Sato S, Chiba T, Sakata E etal. 14-3-3eta is a novel regulator of parkin ubiquitin ligase. EMBO J 2006; 25: 211-221.
57. Lipe H, Bird T. Late onset Huntington Disease: clinical and genetic characteristics of 34 cases. J Neurol Sci 2009; 276: 159-162.
58. Waelter S, Boeddrich A, Lurz R etal. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 2001; 12: 1393-1407.
59. Omi K, Hachiya NS, Tanaka M, Tokunaga K, Kaneko K. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein. Neurosci Lett 2008; 431: 45-50.
60. Wang Y, Meriin AB, Zaarur N etal. Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 2009; 23: 451-463.
61. Uchihara T, Paulus W. Research into neurodegenerative disease: an entangled web of mice and men. Acta Neuropathol 2008; 115: 1-4.
62. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-930.
63. Chapman T, McKeel DW Jr, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 1396-1397.
64. Richard M, Biacabe AG, Streichenberger N etal. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathol 2003; 105: 296-302.
65. Di Fede G, Giaccone G, Limido L etal. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Straussler-Scheinker disease. J Neuropathol Exp Neurol 2007; 66: 124-130.
66. Satoh J, Onoue H, Arima K, Yamamura T. The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular prion protein. J Neuropathol Exp Neurol 2005; 64: 858-868.
67. Pirim I. Ischemic rat brains contain immunoreactivity of 14-3-3 proteins. Int J Neurosci 1998; 95: 101-106.
68. Saito A, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J Neurosci 2003; 23: 1710-1718.
69. Saito A, Narasimhan P, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J Neurosci 2004; 24: 1584-1593.
70. Yang C, Ren Y, Liu F etal. Ischemic preconditioning suppresses apoptosis of rabbit spinal neurocytes by inhibiting ASK1-14-3-3 dissociation. Neurosci Lett 2008; 441: 267-271.
71. Wu JS, Cheung WM, Tsai YS etal. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 2009; 119: 1124-1134.
72. Wu KK. Peroxisome proliferator-activated receptors protect against apoptosis via 14-3-3. PPAR Res 2010; 2010: 1-7.
73. Chen XQ, Chen JG, Zhang Y, Hsiao WW, Yu AC. 14-3-3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes. Glia 2003; 42: 315-324.
74. Chen XQ, Fung YW, Yu AC. Association of 14-3-3gamma and phosphorylated bad attenuates injury in ischemic astrocytes. J Cereb Blood Flow Metab 2005; 25: 338-347.
75. Autieri MV. Inducible expression of the signal transduction protein 14-3-3gamma in injured arteries and stimulated human vascular smooth muscle cells. Exp Mol Pathol 2004; 76: 99-107.
76. Autieri MV, Haines DS, Romanic AM, Ohlstein EH. Expression of 14-3-3 gamma in injured arteries and growth factor- and cytokine-stimulated human vascular smooth muscle cells. Cell Growth Differ 1996; 7: 1453-1460.
77. Hernandez-Ruiz L, Valverde F, Jimenez-Nunez MD etal. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007; 6: 4449-4457.
78. Brunelli L, Cieslik KA, Alcorn JL, Vatta M, Baldini A. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta. Circ Res 2007; 100: e59-e71.
79. Umahara T, Uchihara T, Koyama S etal. Isoform-specific immunolocalization of 14-3-3 proteins in atherosclerotic lesions of human carotid and main cerebral arteries. J Neurol Sci 2012; [in press].
80. Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, Wu KK. Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 2006; 26: 1481-1487.
81. Liu Y, Yin G, Surapisitchat J, Berk BC, Min W. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest 2001; 107: 917-923.
82. Zhang R, He X, Liu W, Lu M, Hsieh JT, Min W. AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest 2003; 111: 1933-1943.
83. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965; 124: 319-335.
84. Seki T, Arai Y. The persistent expression of a highly polysialylated NCAM in the dentate gyrus of the adult rat. Neurosci Res 1991; 12: 503-513.
85. Eriksson PS, Perfilieva E, Bjork-Eriksson T etal. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313-1317.
86. Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 2010; 11: 339-350.
87. LeVine SM, Goldman JE. Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum. J Comp Neurol 1988; 277: 441-455.
88. Watanabe M, Isobe T, Ichimura T etal. Molecular cloning of rat cDNAs for the zeta and theta subtypes of 14-3-3 protein and differential distributions of their mRNAs in the brain. Brain Res Mol Brain Res 1994; 25: 113-121.